معرفی
Dr. Amelia Cossart serves as an Honorary Lecturer at The University of Queensland's School of Pharmacy and Pharmaceutical Sciences, contributing to Australia's leading pharmacy education and research institution through specialized clinical investigations.
Her academic foundation includes a PhD from The University of Queensland (2022), where her thesis "Optimising immunosuppressant medicines in elderly kidney transplant recipients" established her research trajectory. This doctoral work examined medication adherence barriers and pharmacokinetic challenges in aging transplant populations using mixed-methods approaches.
Dr. Cossart's research program centers on critical gaps in transplant pharmacotherapy, with primary emphases on:
- Age-related pharmacokinetic variations in immunosuppressant drugs
- Medication adherence barriers among elderly transplant recipients
- Therapeutic drug monitoring optimization
- Clinical pharmacy service evaluation
- Patient-reported outcome measurement
Her methodological approach integrates quantitative registry analyses with qualitative patient interviews to develop clinically actionable insights for complex medication management scenarios.
Analysis of her 15 journal publications (2019-2025) reveals consistent thematic focus on kidney transplantation, with 73% specifically addressing elderly patient populations. Key evolving trends include expanding from pharmacokinetic studies (2019-2021) toward health services research (2022-2025), including digital prescription services and pandemic impacts on substance use. Her work maintains strong clinical relevance through partnerships with transplant centers across Australia and New Zealand.
Dr. Cossart actively collaborates with multi-disciplinary teams including the Safe and Effective Medication Collaborative at UQ, working alongside nephrologists, surgeons, and pharmacists to translate research into practice improvements for vulnerable transplant patients.
